Abstract:Background Cervical cancer is responsible for 10–15% of cancer-related deaths in women worldwide. In China, it is the most common cancer in the female genital tract. However, the genomic profiles of Chinese cervical cancer patients remain unclear. Materials and Methods A total of 129 cervical cancer patients were enrolled in this study (113 squamous, 12 adenocarcinoma, 2 adenosquamous, and 2 neuroendocrine carcinoma). To classify the clinical features and molecular characteristics of cervical cancer, the genomic alterations of 618 selected genes were analyzed in the samples of these patients, utilizing target next-generation sequencing (NGS) technology. Furthermore, the findings from the Chinese cohort were then compared with the data of Western patients downloaded from The Cancer Genome Atlas (TCGA) database, in terms of gene expression files, mutation data, and clinical information. Results All studied patients had valid somatic gene alterations, and the most frequently altered genes were PIK3C , TP53 , FBXW7 , ARID1A , ERBB2 , and PTEN . Comparison of genomic profiling showed significantly different prevalence of genes, including TP53, KMT2C , and RET , between the Chinese and the TCGA cohorts. Moreover, 57 patients (44.19%) with 83 actionable alterations were identified in our cohort, especially in PI3K and DNA damage repair (DDR) pathways. After an in-depth analysis of cervical cancer data from the TCGA cohort, DDR alteration was found to be associated with extremely higher tumor mutation burden (TMB) (median mutation count: 149.5 vs 66, p <0.0001), and advanced stages (p <0.05). Additionally, DDR alteration, regardless of its function, was positively correlated with hypoxia feature and score. Moreover, patients with a high hypoxia score were positively correlated with a high abundance of mast cell resting, but lower abundance of CD8+ T cells and activated mast cell. Finally, CDHR5 was identified as the hub gene to be involved in the DDR–hypoxia network, which was negatively correlated with both the DDR alteration and hypoxia score. Conclusions Overall, a unique genomic profiling of Chinese patients with cervical cancer was uncovered. Besides, the prevalent actionable variants, especially in PI3K and DDR pathways, would help promote the clinical management. Moreover, DDR alteration exerted the significant influence on the tumor microenvironment in cervical cancer, which could guide the clinical decisions for the treatment. CDHR5 was the first identified hub gene to be negatively correlated with DDR or hypoxia in cervical cancer, which had potential effects on the treatment of immune checkpoint inhibitors (ICIs).

Widespread genomic/molecular alterations of DNA helicases and their clinical/therapeutic implications across human cancer

The roles of RNA helicases in DNA damage repair and tumorigenesis reveal precision therapeutic strategies

The chromatin structuring protein HMGA2 influences human subtelomere stability and cancer chemosensitivity

Molecular characteristics and oncogenic role of CHD family genes: a pan-cancer analysis based on bioinformatic and biological analysis

High Levels of DEAH-Box Helicases Relate to Poor Prognosis and Reduction of DHX9 Improves Radiosensitivity of Hepatocellular Carcinoma

Genomic Profiling of Chinese Cervical Cancer Patients Reveals Prevalence of DNA Damage Repair Gene Alterations and Related Hypoxia Feature

DNAJA2 deficiency activates cGAS-STING pathway via the induction of aberrant mitosis and chromosome instability

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types

Abstract 7106: Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy

The G4 Resolvase DHX36 Possesses a Prognosis Significance and Exerts Tumour Suppressing Function Through Multiple Causal Regulations in Non-Small Cell Lung Cancer

Systematic analysis of DNA polymerases as therapeutic targets in pan-cancers

Integrative Bioinformatics Analysis of WDHD1: a Potential Biomarker for Pan-Cancer Prognosis, Diagnosis, and Immunotherapy

Enzyme family-centred approach identifies helicases as recurrent hemizygous tumour suppressor genes

"From molecular to clinic": The pivotal role of CDC42 in pathophysiology of human papilloma virus related cancers and a correlated sensitivity of afatinib

The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer

Pan-cancer Analysis of DNA Epigenetic Modifications by Hydrophilic Interaction Liquid Chromatography-Tandem Mass Spectrometry

Dna-Pkcs Inhibition Impairs Hdac6-Mediated Hsp90 Chaperone Function On Aurora A And Enhances Hdacs Inhibitor-Induced Cell Killing By Increasing Mitotic Aberrant Spindle Assembly

CK2-HTATSF1-TOPBP1 Signaling Axis Modulates Tumor Chemotherapy Response

Abstract B007: Mutations in chromatin remodelers produce intra-chromosomal deletions in cancer cells

Extrachromosomal DNA Couples with ATM-mediated DNA Damage Response for Genome Instability in Tumors